Jonathan Robertson

Learn More
The CC-chemokine receptor 4 (CCR4) is thought potentially to play a critical role in asthma pathogenesis due to its ability to recruit type 2 T-helper lymphocytes to the inflamed airways. Therefore, CCR4 provides an excellent target for anti-inflammatory therapy. The safety, tolerability, pharmacokinetics and pharmacodynamics of the CCR4 antagonist(More)
  • 1